[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 114,820
Sort by:

2019 Mycosis Fungoides Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Mycosis Fungoides Ongoing Clinical Trials Study” analyzes the current scenario of all active Mycosis Fungoides trials across the world. The report presents ...

February 2019 115 pages

2019 Myelofibrosis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myelofibrosis Ongoing Clinical Trials Study” analyzes the current scenario of all active Myelofibrosis trials across the world. The report presents top level analysis ...

February 2019 152 pages

2019 Myeloid Metaplasia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myeloid Metaplasia Ongoing Clinical Trials Study” analyzes the current scenario of all active Myeloid Metaplasia trials across the world. The report presents ...

February 2019 34 pages

2019 Myelopathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myelopathy Ongoing Clinical Trials Study” analyzes the current scenario of all active Myelopathy trials across the world. The report presents top level analysis ...

February 2019 50 pages

2019 Myeloproliferative Disorders Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myeloproliferative Disorders Ongoing Clinical Trials Study” analyzes the current scenario of all active Myeloproliferative Disorders trials across the world. The report presents ...

February 2019 260 pages

2019 Myocardial Infarction Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myocardial Infarction Ongoing Clinical Trials Study” analyzes the current scenario of all active Myocardial Infarction trials across the world. The report presents ...

February 2019 327 pages

2019 Myocardial Ischemia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myocardial Ischemia Ongoing Clinical Trials Study” analyzes the current scenario of all active Myocardial Ischemia trials across the world. The report presents ...

February 2019 80 pages

2019 Myoclonic Seizure Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myoclonic Seizure Ongoing Clinical Trials Study” analyzes the current scenario of all active Myoclonic Seizure trials across the world. The report presents ...

February 2019 63 pages

2019 Myopia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myopia Ongoing Clinical Trials Study” analyzes the current scenario of all active Myopia trials across the world. The report presents top level analysis ...

February 2019 64 pages

2019 Myxoid Liposarcoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Myxoid Liposarcoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Myxoid Liposarcoma trials across the world. The report presents ...

February 2019 48 pages

2019 Narcolepsy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Narcolepsy Ongoing Clinical Trials Study” analyzes the current scenario of all active Narcolepsy trials across the world. The report presents top level analysis ...

February 2019 50 pages

2019 Nasal Congestion Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nasal Congestion Ongoing Clinical Trials Study” analyzes the current scenario of all active Nasal Congestion trials ... for administering Nasal Congestion patients are identified The report includes panorama of ongoing Nasal Congestion clinical trials across ...

February 2019 37 pages

2019 Nasal Obstruction Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nasal Obstruction Ongoing Clinical Trials Study” analyzes the current scenario of all active Nasal Obstruction trials across the world. The report presents ...

February 2019 38 pages

2019 Nasal Polyposis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nasal Polyposis Ongoing Clinical Trials Study” analyzes the current scenario of all active Nasal Polyposis trials ... for administering Nasal Polyposis patients are identified The report includes panorama of ongoing Nasal Polyposis clinical trials across ...

February 2019 48 pages

2019 Nasal Polyps (Nasal Polyposis) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... clinical trial research report- “2019 Nasal Polyps (Nasal Polyposis) Ongoing Clinical Trials Study” analyzes the current scenario of all active Nasal Polyps (Nasal Polyposis) trials across the world ...

February 2019 86 pages

2019 Nasopharyngeal Cancer Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nasopharyngeal Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Nasopharyngeal Cancer trials across the world. The report presents ...

February 2019 203 pages

2019 Natural Killer Cell Lymphomas Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... clinical trial research report- “2019 Natural Killer Cell Lymphomas Ongoing Clinical Trials Study” analyzes the current scenario of all active Natural Killer Cell Lymphomas trials across the world ...

February 2019 112 pages

2019 Nausea Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nausea Ongoing Clinical Trials Study” analyzes the current scenario of all active Nausea trials across the world. The report presents top level analysis ...

February 2019 96 pages

2019 Neck Pain Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neck Pain Ongoing Clinical Trials Study” analyzes the current scenario of all active Neck Pain trials across the ... being researched for administering Neck Pain patients are identified The report includes panorama of ongoing Neck Pain clinical trials across the ...

February 2019 43 pages

2019 Neisseria meningitidis Infections Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Neisseria meningitidis Infections Ongoing Clinical Trials Study” analyzes the current scenario of all active Neisseria meningitidis Infections trials across the world. The report ...

February 2019 58 pages

2019 Neonatal Respiratory Distress Syndrome Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... clinical trial research report- “2019 Neonatal Respiratory Distress Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Neonatal Respiratory Distress Syndrome trials across the world ...

February 2019 47 pages

2019 Neonatal Seizures Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neonatal Seizures Ongoing Clinical Trials Study” analyzes the current scenario of all active Neonatal Seizures trials across the world. The report presents ...

February 2019 40 pages

2019 Neoplastic Syndrome Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neoplastic Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Neoplastic Syndrome trials across the world. The report presents ...

February 2019 34 pages

2019 Neovascular Glaucoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neovascular Glaucoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Neovascular Glaucoma trials across the world. The report presents ...

February 2019 39 pages

2019 Nephroblastoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nephroblastoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Nephroblastoma trials across the world. The report presents top level analysis ...

February 2019 61 pages

2019 Nephropathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nephropathy Ongoing Clinical Trials Study” analyzes the current scenario of all active Nephropathy trials across the world. The report presents top level analysis ...

February 2019 117 pages

2019 Nephrotic Syndrome Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nephrotic Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Nephrotic Syndrome trials across the world. The report presents ...

February 2019 91 pages

2019 Neuralgia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neuralgia Ongoing Clinical Trials Study” analyzes the current scenario of all active Neuralgia trials across the world. The report presents top level analysis ...

February 2019 178 pages

2019 Neuroblastoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neuroblastoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Neuroblastoma trials across the world. The report presents top level analysis ...

February 2019 205 pages

2019 Neuroendocrine Cancer Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neuroendocrine Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Neuroendocrine Cancer trials across the world. The report presents ...

February 2019 257 pages

2019 Neuroendocrine Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neuroendocrine Carcinoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Neuroendocrine Carcinoma trials across the world. The report presents ...

February 2019 98 pages

2019 Neurofibromatoses Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neurofibromatoses Ongoing Clinical Trials Study” analyzes the current scenario of all active Neurofibromatoses trials across the world. The report presents top level analysis ...

February 2019 75 pages

2019 Neurofibromatoses Type I Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Neurofibromatoses Type I Ongoing Clinical Trials Study” analyzes the current scenario of all active Neurofibromatoses Type I trials across the world. The report ...

February 2019 59 pages

2019 Neurofibrosarcoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neurofibrosarcoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Neurofibrosarcoma trials across the world. The report presents top level analysis ...

February 2019 66 pages

2019 Neuromyelitis Optica Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neuromyelitis Optica Ongoing Clinical Trials Study” analyzes the current scenario of all active Neuromyelitis Optica trials across the world. The report presents ...

February 2019 61 pages

2019 Neuropathic Pain Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neuropathic Pain Ongoing Clinical Trials Study” analyzes the current scenario of all active Neuropathic Pain trials ... for administering Neuropathic Pain patients are identified The report includes panorama of ongoing Neuropathic Pain clinical trials across ...

February 2019 165 pages

2019 Neuropathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neuropathy Ongoing Clinical Trials Study” analyzes the current scenario of all active Neuropathy trials across the world. The report presents top level analysis ...

February 2019 134 pages

2019 Neurotoxicity Syndromes Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neurotoxicity Syndromes Ongoing Clinical Trials Study” analyzes the current scenario of all active Neurotoxicity Syndromes trials across the world. The report presents ...

February 2019 47 pages

2019 Neutropenia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Neutropenia Ongoing Clinical Trials Study” analyzes the current scenario of all active Neutropenia trials across the world. The report presents top level analysis ...

February 2019 113 pages

2019 Nevus Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nevus Ongoing Clinical Trials Study” analyzes the current scenario of all active Nevus trials across the world. The report presents top level analysis ...

February 2019 37 pages

2019 Nicotine Addiction Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nicotine Addiction Ongoing Clinical Trials Study” analyzes the current scenario of all active Nicotine Addiction trials across the world. The report presents ...

February 2019 112 pages

2019 Nocturia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nocturia Ongoing Clinical Trials Study” analyzes the current scenario of all active Nocturia trials across the world. The report presents top level analysis ...

February 2019 51 pages

2019 Nocturnal Enuresis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Nocturnal Enuresis Ongoing Clinical Trials Study” analyzes the current scenario of all active Nocturnal Enuresis trials across the world. The report presents ...

February 2019 37 pages

2019 Non Alcoholic Fatty Liver Disease (NAFLD) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Non Alcoholic Fatty Liver Disease (NAFLD) Ongoing Clinical Trials Study” analyzes the current scenario of all active Non Alcoholic Fatty Liver Disease (NAFLD) trials ...

February 2019 156 pages

2019 Non Malignant pain Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Non Malignant pain Ongoing Clinical Trials Study” analyzes the current scenario of all active Non Malignant pain trials across the world. The report ...

February 2019 32 pages

2019 Non-Alcoholic Steatohepatitis (NASH) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Non-Alcoholic Steatohepatitis (NASH) Ongoing Clinical Trials Study” analyzes the current scenario of all active Non-Alcoholic Steatohepatitis (NASH) trials across the world. The report ...

February 2019 146 pages

2019 Nondiarrhea - Associated Hemolytic Uremic Syndrome Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Nondiarrhea - Associated Hemolytic Uremic Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Nondiarrhea - Associated Hemolytic Uremic Syndrome trials ...

February 2019 46 pages

2019 Nonerosive Reflux Disease (NERD) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... clinical trial research report- “2019 Nonerosive Reflux Disease (NERD) Ongoing Clinical Trials Study” analyzes the current scenario of all active Nonerosive Reflux Disease (NERD) trials across the world ...

February 2019 39 pages

2019 Non-ischemic Cardiomyopathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Non-ischemic Cardiomyopathy Ongoing Clinical Trials Study” analyzes the current scenario of all active Non-ischemic Cardiomyopathy trials across the world. The report presents ...

February 2019 38 pages

2019 Non-Proliferative Diabetic Retinopathy (NPDR) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... clinical trial research report- “2019 Non-Proliferative Diabetic Retinopathy (NPDR) Ongoing Clinical Trials Study” analyzes the current scenario of all active Non-Proliferative Diabetic Retinopathy (NPDR) trials across the world ...

February 2019 47 pages

Filters

Search

Categories

112,326
373
94
238
546
1,149
94

Publishers

179
1
123
148
2,647
103
25
102
103
2,628
232
23
40
8,299
68
563
597
34
29,954
248
501
3,036
1
1
2
3
16
257
537
361
106
1
1,357
60
1,696
8
8,921
1,982
4
3,674
1,550
19
1
321
4,852
2,756
66
1
3
3
36
202
2,355
246
53
50
45
46
29
29
143
56
42
83
9
20
29
5
11
3
16,308
3
281
11
3
292
22
4
39
1
2
6,125
14
1
183
49
359
30
34
4,348
13
1
44
2
7
10
9
12
18
21
168
52
8
3
18
16
7
1
18
1
41
58
649
1
4
6
1
9
3
5
1
1
1
92
2
4
4
1
83
15
1,247
1
3
1
17
227
128
16
4
397
3
74
2
6
5
10
1
3
119
33
336
207
47
474
7
45
1
25
13
138
2
4

Regions

65
57
56
48
38
35
35
31
31
30
29
29
26
26
25
23
22
22
21
16
15
14
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
52
1,734
52
3
34
2
2
1,177
115
172
26
33
93
14
49
54
28
18
58
25
23
39
23
39
24
14
48
28
34
139
46
60
63
207
48
17
52
39
30
52
43
41
37
19
55
145
34
30
28
17
17
16
14
105
40
133
53
45
29
22
457
1,818
67
921
754
180
2,010
102,054

Price

Date

Pages

Offers

98
23
1
2,743
280
1